Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WTFJV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
39870768 20D9h3-DUBA
|
|||||
| Synonyms |
20D9h3-DUBA
Click to Show/Hide
|
|||||
| Organization |
LMU Munich; Leibniz-Forschungsinstitut für Molekulare Pharmakologie; Humboldt Universität zu Berlin; Tubulis GmbH; German Cancer Consortium (DKTK); Helmholtz Munich; University Hospital Ulm; German Cancer Research Center (DKFZ); Technical University of Munich; Bavarian Cancer Research Center (BZKF).
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.8
|
|||||
| Antibody Name |
20D9h3
|
Antibody Info | ||||
| Antigen Name |
Receptor-type tyrosine-protein kinase FLT3 (FLT3)
|
Antigen Info | ||||
| Payload Name |
Seco-DUBA
|
Payload Info | ||||
| Therapeutic Target |
Human deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||